| Product Code: ETC13365787 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Pharmacogenomics Technology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Pharmacogenomics Technology Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Europe Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.9 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
4 Europe Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Pharmacogenomics Technology Market Trends |
6 Europe Pharmacogenomics Technology Market, 2021 - 2031 |
6.1 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Genotyping, 2021 - 2031 |
6.1.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Gene Expression Profiling, 2021 - 2031 |
6.1.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Bioinformatics Solutions, 2020 - 2028 |
6.1.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Companion Diagnostics, 2020 - 2028 |
6.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Drug Response Analysis, 2021 - 2031 |
6.2.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Oncology Treatment, 2021 - 2031 |
6.2.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031 |
6.2.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Clinical Trials, 2020 - 2028 |
6.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By PCR-Based, 2021 - 2031 |
6.3.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Microarray, 2021 - 2031 |
6.3.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.3.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By AI-Based Analytics, 2021 - 2031 |
6.3.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Pharma Companies, 2021 - 2031 |
6.4.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Research Labs, 2020 - 2028 |
6.4.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Academic Institutions, 2020 - 2028 |
6.4.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Diagnostic Centers, 2020 - 2028 |
6.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Advancements in Precision Medicine, 2020 - 2028 |
6.5.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Increase in Genetic Testing, 2020 - 2028 |
6.5.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Growing Interest in Targeted Therapy, 2020 - 2028 |
6.5.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Expansion in Pharmacovigilance, 2020 - 2028 |
6.5.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Demand for Tailored Therapeutics, 2020 - 2028 |
7 Europe Pharmacogenomics Technology Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.2 Germany Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.3 France Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.4 Poland Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.5 Spain Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.6 Rest of Europe Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3 Europe Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United Kingdom (UK) Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Germany Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 France Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Poland Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.5 Spain Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.6 Rest of Europe Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.1 United Kingdom (UK) Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.2 Germany Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.3 France Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.4 Poland Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.5 Spain Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.6 Rest of Europe Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.1 United Kingdom (UK) Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.2 Germany Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.3 France Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.4 Poland Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.5 Spain Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.6 Rest of Europe Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
8 Europe Pharmacogenomics Technology Market Key Performance Indicators |
9 Europe Pharmacogenomics Technology Market - Export/Import By Countries Assessment |
10 Europe Pharmacogenomics Technology Market - Opportunity Assessment |
10.1 Europe Pharmacogenomics Technology Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.3 Europe Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Europe Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
10.5 Europe Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Europe Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
11 Europe Pharmacogenomics Technology Market - Competitive Landscape |
11.1 Europe Pharmacogenomics Technology Market Revenue Share, By Companies, 2022 |
11.2 Europe Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here